{"id":"ifosphamide-etoposide-methotrexate-vindelsine-prednisone","safety":{"commonSideEffects":[{"rate":"50-70%","effect":"Myelosuppression"},{"rate":"30-50%","effect":"Nausea and vomiting"},{"rate":"20-40%","effect":"Hair loss"},{"rate":"10-30%","effect":"Diarrhea"},{"rate":"5-20%","effect":"Stomatitis"}]},"_chembl":{"chemblId":"CHEMBL1200645","moleculeType":"Small molecule","molecularWeight":"668.54"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Ifosphamide is a topoisomerase II inhibitor that works by interfering with the enzyme topoisomerase II, which is involved in DNA replication and transcription. This leads to DNA damage and ultimately cell death.","oneSentence":"Topoisomerase inhibitor","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:35:07.441Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute lymphoblastic leukemia"},{"name":"Breast cancer"},{"name":"Lymphoma"},{"name":"Ovarian cancer"},{"name":"Testicular cancer"}]},"trialDetails":[{"nctId":"NCT02405676","phase":"PHASE2, PHASE3","title":"BNHL-2015 for Children or Adolescents in China","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Cancer Group, China","startDate":"2015-01-01","conditions":"Mature B-cell Non-Hodgkin Lymphoma","enrollment":200},{"nctId":"NCT07168980","phase":"PHASE2, PHASE3","title":"Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents","status":"RECRUITING","sponsor":"Children's Cancer Group, China","startDate":"2025-07-01","conditions":"Mature B-cell Non-Hodgkin Lymphoma","enrollment":87}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Protocol BB"],"phase":"phase_2","status":"active","brandName":"Ifosphamide, Etoposide, Methotrexate, Vindelsine, Prednisone","genericName":"Ifosphamide, Etoposide, Methotrexate, Vindelsine, Prednisone","companyName":"Children's Cancer Group, China","companyId":"children-s-cancer-group-china","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Topoisomerase inhibitor Used for Acute lymphoblastic leukemia, Breast cancer, Lymphoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}